Novel three-dimensional biochip pulmonary sarcoidosis model

Sarcoidosis is a multi-system disorder of granulomatous inflammation which most commonly affects the lungs. Its etiology and pathogenesis are not well defined in part due to the lack of reliable modeling. Here, we present the development of an in vitro three-dimensional lung-on-chip biochip designed to mimic granuloma formation. A lung on chip fluidic macrodevice was developed and added to our previously developed a lung-on-membrane model (LOMM). Granulomas were cultured from blood samples of patients with sarcoidosis and then inserted in the air-lung-interface of the microchip to create a three-dimensional biochip pulmonary sarcoidosis model (3D BSGM). Cytokines were measured after 48 hours. ELISA testing was performed to measure cytokine response difference between LOMM with 3D BSGM. There were statistically significant differences in IL-1ss (P = 0.001953), IL-6 (P = 0.001953), GM-CSF (P = 0.001953), and INF-gamma expressions (P = 0.09375) between two groups. The current model represents the first 3D biochip sarcoidosis model created by adding a microfluidics system to a dual-chambered lung on membrane model and introducing developed sarcoid-granuloma to its air-lung-interface.

Automated summary

The article introduces a new method for creating a sarcoidosis model in vitro by inserting granulomas into the air-lung interface of a lung-on-chip biochip, mimicking the formation of granulomas. Using ELISA testing to detect differences in cytokine responses, statistically significant differences were found in the expression of IL-1ss, IL-6, GM-CSF, and INF-γ between the two groups.